Thomas Patrick Kelly

CIK 1410514 · Chief Financial Officer · last filed 2025-10-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

36

Lifetime Open-Market Net

-$6.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XENE Chief Financial Officer $52.10 $0 1 2025-10-17
Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Chief Financial Officer 0 $25.59 $0 -$6.54M 31 2024-06-11
CORNERSTONE THERAPEUTICS INC (CRTX) Delisted CFO & SVP Finance & Corp. Dev, 90,700 $1.95 $176.9K $8.3K 4 2008-02-19

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-02-20 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Grant (A) $0 EDGAR
2017-10-02 Deciphera Pharmaceuticals, Inc. (DCPH) Delisted Exer (M) $0 EDGAR
2008-02-19 CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Grant (A) +35,000 $35 EDGAR
2007-11-07 CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Grant (A) +25,000 $25 EDGAR
2007-08-22 CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Grant (A) +26,700 $27 EDGAR
2007-08-22 CORNERSTONE THERAPEUTICS INC (CRTX) Delisted Buy (P) +4,000 $8.3K EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.